These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35463733)

  • 1. Significance of Endocan Expression in Various Types of Epithelial Ovarian Tumors.
    Entezarian M; Ameli F; Masir N; Chin TG
    Iran J Pathol; 2022; 17(2):202-209. PubMed ID: 35463733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocan-microvascular Density in Primary Ovarian Carcinoma.
    Baba F; Yajid AI; Mohd Nafi SN; Ab Hamid SA; Wan Adnan WNA; Che Jalil NA
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):929-935. PubMed ID: 35345365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.
    El Behery MM; Seksaka MA; Ibrahiem MA; Saleh HS; El Alfy Y
    Arch Gynecol Obstet; 2013 Dec; 288(6):1371-6. PubMed ID: 23708323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
    Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
    World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum endocan levels in endometrial and ovarian cancers.
    Laloglu E; Kumtepe Y; Aksoy H; Topdagi Yilmaz EP
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27734523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study.
    Naik PS; Deshmukh S; Khandeparkar SG; Joshi A; Babanagare S; Potdar J; Risbud NS
    J Midlife Health; 2015; 6(4):178-83. PubMed ID: 26903759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
    Miao Y; Zong M; Jiang T; Yuan X; Guan S; Wang Y; Zhou D
    Pituitary; 2016 Apr; 19(2):194-201. PubMed ID: 26809958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53, bcl-2, ki-67 li (labeling index) status in benign, proliferative, and malignant ovarian surface epithelial neoplasms.
    Gursan N; Sipal S; Calik M; Gundogdu C
    Eurasian J Med; 2009 Apr; 41(1):10-4. PubMed ID: 25610057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
    Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A
    Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocan: A new marker for cancer and a target for cancer therapy.
    Yang J; Yang Q; Yu S; Zhang X
    Biomed Rep; 2015 May; 3(3):279-283. PubMed ID: 26137222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
    Giurgea LN; Ungureanu C; Mihailovici MS
    Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.
    Sarrazin S; Adam E; Lyon M; Depontieu F; Motte V; Landolfi C; Lortat-Jacob H; Bechard D; Lassalle P; Delehedde M
    Biochim Biophys Acta; 2006 Jan; 1765(1):25-37. PubMed ID: 16168566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms.
    Alkhateeb KJ; Crane JE; Sak M; Jorgensen CJ; O'Donnell JP; Zumbar CT; Wozniak JA; Salazar CR; Parwani AV; Lehman NL
    Diagn Pathol; 2021 Oct; 16(1):98. PubMed ID: 34706741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
    Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].
    Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX
    Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
    Song JY; Chen KY; Kim SY; Kim MR; Ryu KS; Cha JH; Kang CS; MacLaughlin DT; Kim JH
    Int J Oncol; 2009 Jun; 34(6):1583-91. PubMed ID: 19424576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.